We are live on
!
Find out more
VEA
Virtus ETF Advisers Portfolio holdings
AUM
$215M
1-Year Est. Return
53.68%
This Fund
S&P 500
This Quarter
Est. Return
+12.8%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$237M
AUM Growth
-$4.18M
(-1.7%)
Cap. Flow
-$18.3M
Cap. Flow
% of AUM
-7.71%
Top 10 Holdings %
Top 10 Hldgs %
7.93%
Holding
416
New
61
Increased
247
Reduced
47
Closed
61
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.78M |
| 2 |
EOG Resources
EOG
|
+$1.78M |
| 3 |
ConocoPhillips
COP
|
+$1.72M |
| 4 |
Imperial Oil
IMO
|
+$1.64M |
| 5 |
Vornado Realty Trust
VNO
|
+$1.59M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ryman Hospitality Properties
RHP
|
+$2.57M |
| 2 |
Western Midstream Partners
WES
|
+$2.52M |
| 3 |
INN
Summit Hotel Properties
INN
|
+$2.43M |
| 4 |
Brookfield Renewable
BEPC
|
+$2.38M |
| 5 |
Grupo Aeroportuario del Pacifico
PAC
|
+$2.16M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.46% |
| 2 | Real Estate | 18.03% |
| 3 | Energy | 13.68% |
| 4 | Materials | 11.34% |
| 5 | Utilities | 10.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Viking Therapeutics
VKTX
$3.88B
| $283K | 0.12% |
44,755
+789
| +2% | +$5.55K |
|
252
Xencor
XNCR
$1.45B
| $282K | 0.12% |
6,543
+117
| +2% | +$5.54K |
|
|
TECX
253
Tectonic Therapeutic
TECX
$536M
| $282K | 0.12% |
1,854
+33
| +2% | +$5.37K |
|
254
Oxford Square Capital
OXSQ
$150M
| $281K | 0.12% |
60,656
-9,080
| -13% | -$35.3K |
|
255
BioXcel Therapeutics
BTAI
$24.8M
| $280K | 0.12% |
405
+7
| +2% | +$5.63K |
|
|
EVF
256
Eaton Vance Senior Income Trust
EVF
$90.1M
| $280K | 0.12% |
42,193
+4,301
| +11% | +$28.3K |
|
|
EFF
257
DELISTED
EATON VANCE FLOATING-RATE INCOME PLUS FUND
EFF
| $278K | 0.12% |
17,104
+2,866
| +20% | +$45.5K |
|
258
ALX Oncology
ALXO
$262M
| $277K | 0.12% |
3,758
+70
| +2% | +$5.51K |
|
|
BRW
259
Saba Capital Income & Opportunities Fund
BRW
$335M
| $276K | 0.12% |
29,723
+4,815
| +19% | +$43.9K |
|
|
RAPT
260
DELISTED
RAPT Therapeutics
RAPT
| $275K | 0.12% |
1,548
+29
| +2% | +$4.78K |
|
261
Sarepta Therapeutics
SRPT
$1.64B
| $275K | 0.12% |
3,686
+96
| +3% | +$8.86K |
|
|
BCEL
262
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $274K | 0.12% |
17,856
+306
| +2% | +$4.97K |
|
|
OYST
263
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $274K | 0.12% |
14,995
+266
| +2% | +$5.58K |
|
264
Geron
GERN
$898M
| $273K | 0.12% |
172,591
+3,044
| +2% | +$5.44K |
|
265
XBiotech
XBIT
$68.6M
| $273K | 0.12% |
15,872
+288
| +2% | +$5.38K |
|
266
AnaptysBio
ANAB
$1.54B
| $269K | 0.11% |
12,476
+225
| +2% | +$5.68K |
|
267
Cue Biopharma
CUE
$118M
| $269K | 0.11% |
735
+13
| +2% | +$5.35K |
|
|
ETNB
268
DELISTED
89bio
ETNB
| $269K | 0.11% |
11,351
+197
| +2% | +$4.55K |
|
269
Inovio Pharmaceuticals
INO
$85.6M
| $268K | 0.11% |
2,404
+42
| +2% | +$5.52K |
|
|
GMDA
270
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
| $267K | 0.11% |
33,042
+587
| +2% | +$5.39K |
|
|
ISEE
271
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $267K | 0.11% |
43,267
+758
| +2% | +$4.6K |
|
272
Arrowhead Research
ARWR
$12.1B
| $266K | 0.11% |
4,006
+68
| +2% | +$5.28K |
|
273
Syndax Pharmaceuticals
SNDX
$1.7B
| $264K | 0.11% |
11,828
+204
| +2% | +$4.61K |
|
|
KDMN
274
DELISTED
Kadmon Holdings, Inc.
KDMN
| $264K | 0.11% |
67,781
+1,187
| +2% | +$5.44K |
|
275
Gossamer Bio
GOSS
$101M
| $263K | 0.11% |
28,463
+500
| +2% | +$5.04K |
|
Similar funds
NCM
SSA
LIWM
VFG
IAM
1M
GC
RC
Virtus ETF Advisers's Q1 2021 Portfolio in Review
As of Q1 2021, Virtus ETF Advisers held 416 positions worth $237M, down 1.7% from $241M the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Virtus ETF Advisers withdrew a net $18.3M in Q1 2021, closing 61 positions and reducing 47 holdings. Its most notable exit was Ryman Hospitality Properties, an estimated $2.57M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 30% a quarter earlier, followed by Real Estate and Energy.
Against the trend, Virtus ETF Advisers opened a new position in Pioneer Natural Resource Co. worth $1.99M.
- Virtus ETF Advisers's largest Q1 2021 buy was Pioneer Natural Resource Co.: 12,538 shares worth $1.99M.
- Virtus ETF Advisers added most to Oaktree Specialty Lending in Q1 2021, an estimated $216K increase.
- Virtus ETF Advisers's biggest Q1 2021 reduction was Avient, cutting an estimated $916K.
- Virtus ETF Advisers fully exited Ryman Hospitality Properties in Q1 2021, selling an estimated $2.57M.
- Virtus ETF Advisers's ten largest holdings make up 7.9% of its $237M portfolio in Q1 2021.
- Virtus ETF Advisers opened 61 new positions and closed 61 in Q1 2021.
- Virtus ETF Advisers's portfolio value fell 1.7% quarter-over-quarter to $237M.
Based on Virtus ETF Advisers's 13F filing for Q1 2021, filed 17 May 2021.